SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-17-052272
Filing Date
2017-10-12
Accepted
2017-10-12 16:56:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 v476435_424b3.htm 424B3 166347
2 GRAPHIC v476435_img01.jpg GRAPHIC 10407
  Complete submission text file 0001144204-17-052272.txt   181886
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-220822 | Film No.: 171134965
SIC: 8731 Services-Commercial Physical & Biological Research